Which superinvestors hold Gsk Plc-Spon Adr (GSK)?

Per the latest SEC 13F filings, 6 superinvestors hold Gsk Plc-Spon Adr (GSK): Dodge & Cox, Ray Dalio, Thomas Kahn, Tweedy, Browne, Richard Pzena, Sarah Ketterer. Combined value held is about $3.29B, with Dodge & Cox the largest holder.

Gsk Plc-Spon Adr

Held by 6 superinvestors (GSK).

Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.

Ownership · 13F consensus

Who's buying it

Institutional ownership aggregated across funds — consensus strength and this quarter's moves. Describes actions, not advice.

6 superinvestors hold it · $3.29B combined

This quarter1 added5 trimmed

Largest holder Dodge & Cox

13F positions are self-reported and can lag up to 45 days. Informational only — not investment advice.

Next · is it cheap

Want to see which stocks look cheap against a conservative value band?

Browse all valued stocks, ranked by value band

Superinvestors Holding This Security

Investor	Value	Shares	Weight (prev→now)
Dodge & Cox	$3.24B	58,662,974	1.8% → 1.8% ▼
Ray Dalio	$38.6M	698,666	0.3% → 0.2% ▼
Thomas Kahn	$8.9M	160,982	1.6% → 1.6% ▼
Tweedy, Browne	$4.5M	81,785	0.3% → 0.4% ▼
Richard Pzena	$1.0M	18,823	0.0% → 0.0% ▲
Sarah Ketterer	$613,177	11,110	0.0% → 0.0% ▼

Dodge & Cox
Value$3.24BWeight (prev→now)1.8% → 1.8% ▼
Ray Dalio
Value$38.6MWeight (prev→now)0.3% → 0.2% ▼
Thomas Kahn
Value$8.9MWeight (prev→now)1.6% → 1.6% ▼
Tweedy, Browne
Value$4.5MWeight (prev→now)0.3% → 0.4% ▼
Richard Pzena
Value$1.0MWeight (prev→now)0.0% → 0.0% ▲
Sarah Ketterer
Value$613,177Weight (prev→now)0.0% → 0.0% ▼

Ownership overview

Gsk Plc-Spon Adr (GSK) is held by 6 of the superinvestors tracked on Compounder, with a combined $3.29B in reported 13F value. The largest position belongs to Dodge & Cox, where it makes up 1.8% of the portfolio.

Other notable holders by value include Ray Dalio (0.2% of its book), Thomas Kahn (1.6% of its book) and Tweedy, Browne (0.4% of its book).

Over the latest quarter, 0 of the tracked filers opened a new position in GSK, 1 added to existing ones, 5 trimmed, and 0 sold out entirely.

Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-03-31. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.

Holders over time

Superinvestors holding this security over the last 8 quarters: 4 → 6.

Early quarters may understate holder counts due to data backfill — read the slope with care.

Key facts & links

Ticker: GSK
Total value held: $3.29B
Largest holder: Dodge & Cox
External

Sources· SEC EDGAR 13F as of 2026-03-31 · filed 2026-05-15

Stay Updated

Curated 13F moves and valuation insights, straight to your inbox.